BiomX Inc. COmmon Stock (PHGE)
Stock · AMEX · Health Care
$0.2915as of 10/8/2026
Price chart
Active signals
No technical signal is currently active for this symbol.
PHGE Signal Track Record
How signals performed across all stocks →What PHGE's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 23 | -26.9% | 22% | September 8, 2026 |
| Bollinger Band Breakdown | 17 | -8.2% | 41% | August 12, 2026 |
| Volume Spike | 12 | -21.0% | 33% | September 23, 2026 |
| 200-Day Moving Average Touch | 8 | -28.7% | 38% | October 23, 2025 |
| Any 20-session window (baseline) | -8.7% | 35% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PHGE
Tessera Defense and Homeland Security Inc. develops and provides defense, homeland security, and critical infrastructure technologies. The company develops threat detection technology for defense and security applications, including counter-drone systems, perimeter and border security, wide-area surveillance, and aerial firefighting. It also provides AI-powered prediction, analysis, validation, coordination, and resp…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 20
- Website
- www.biomx.com/
Fundamentals
- 1-day range
- $1.65$2.16
- Market cap
- $3.95M
- P/E (trailing)
- —
- P/E (forward)
- -0.03
- EPS (trailing)
- $-21.44
- Dividend yield
- —
- Beta
- -1.17
- Avg. volume
- 1.41M
BiomX Inc. COmmon Stock Competitors
Chosen by industry and closest market cap.
- PHGEBiomX Inc. COmmon Stock$0.2915▼ 5.72%Market cap $3.95MP/E —$0.63$122.9
- CLDICalidi Biotherapeutics Inc. Common Stock$0.837▼ 3.79%Market cap $4.38MP/E —$0.82$27.84
- BCABBioAtla Inc. Common Stock$1.36▲ 4.62%Market cap $5.53MP/E —$1.07$71.5
- VIVSVivoSim Labs Inc. Common Stock$0.16▼ 5.88%Market cap $5.53MP/E —$0.1495$3.4
- SLXNSilexion Therapeutics Corp Ordinary Shares$0.153▼ 19.05%Market cap $1.90MP/E —$0.2362$42.6
- PMCBPharmaCyte Biotech Inc. Common Stock$0.3402▼ 4.81%Market cap $6.34MP/E —$0.3339$1.51
- SCNIScinai Immunotherapeutics Ltd. American Depositary Shares$0.752▼ 16.63%Market cap $1.30MP/E 0.16$0.75$15.65
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PHGE BiomX Inc. COmmon Stock | $3.95M | — | $0.2915 | ▼ 5.72% | $0.63$122.9 |
| CLDI Calidi Biotherapeutics Inc. Common Stock | $4.38M | — | $0.837 | ▼ 3.79% | $0.82$27.84 |
| BCAB BioAtla Inc. Common Stock | $5.53M | — | $1.36 | ▲ 4.62% | $1.07$71.5 |
| VIVS VivoSim Labs Inc. Common Stock | $5.53M | — | $0.16 | ▼ 5.88% | $0.1495$3.4 |
| SLXN Silexion Therapeutics Corp Ordinary Shares | $1.90M | — | $0.153 | ▼ 19.05% | $0.2362$42.6 |
| PMCB PharmaCyte Biotech Inc. Common Stock | $6.34M | — | $0.3402 | ▼ 4.81% | $0.3339$1.51 |
| SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares | $1.30M | 0.16 | $0.752 | ▼ 16.63% | $0.75$15.65 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 298.8K
- Total value held
- $1.12M
- Institutional holders
- 12
- Unknown131.3K
- Unknown114.8K
- Unknown19.5K
- Unknown19.1K
- Unknown11.8K
- Unknown1.3K
- Unknown573
- Unknown251
- Unknown200
- Unknown20
See the full, filterable feed with live charts on the MarketWall dashboard.